Literature DB >> 6267177

Two-dimensional gel analysis of HSV type 1-induced polypeptides and glycoprotein processing.

L Haarr, H S Marsden.   

Abstract

Two hundred and thirty virus-induced polypeptides have been detected in BHK cells infected with herpes simplex virus type 1 (HSV-1; strain 17) by means of two-dimensional gel electrophoresis. The polypeptides have been characterized by both relative mobility following isoelectric focusing and apparent mol. wt. in SDS-polyacrylamide gels. Some polypeptides, visualized as a single band on a one-dimensional SDS-polyacrylamide gel, were resolved into several spots. Three were identified in Vmw43, the band thought to contain thymidine kinase activity. Not all the observed polypeptides are unique species: some appear to be related and have altered mobilities as a consequence of post-translational modification events. Pulse-chase experiments and treatment of infected cells with neuraminidase suggested that glycoproteins gB, gC and gD contain sialic acid and that synthesis of gB and gD occurs by at least 15 and 10 discrete steps respectively.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6267177     DOI: 10.1099/0022-1317-52-1-77

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  Composition of pseudorabies virus particles lacking tegument protein US3, UL47, or UL49 or envelope glycoprotein E.

Authors:  Kathrin Michael; Barbara G Klupp; Thomas C Mettenleiter; Axel Karger
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  DNA sequence of the herpes simplex virus type 1 gene whose product is responsible for transcriptional activation of immediate early promoters.

Authors:  M A Dalrymple; D J McGeoch; A J Davison; C M Preston
Journal:  Nucleic Acids Res       Date:  1985-11-11       Impact factor: 16.971

3.  Analysis of the transcript of the herpes simplex virus DNA polymerase gene provides evidence that polymerase expression is inefficient at the level of translation.

Authors:  D R Yager; D M Coen
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

4.  Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells.

Authors:  D C Johnson; P G Spear
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

5.  Analysis of the TK enzyme complex induced by HSV types 1 and 2 by means of isoelectric focusing and polyacrylamide gel electrophoresis.

Authors:  J Labenz; D Friedrich; D Falke
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

6.  The characterization and purification of DNA binding proteins present within herpes simplex virus infected cells using monoclonal antibodies.

Authors:  N B la Thangue; W L Chan
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

7.  Characterization of the herpes simplex virus type 1 glycoprotein D mRNA and expression of this protein in Xenopus oocytes.

Authors:  R J Watson; A M Colberg-Poley; C J Marcus-Sekura; B J Carter; L W Enquist
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  Application of denatured, electrophoretically separated, and immobilized lysates of herpes simplex virus-infected cells for detection of monoclonal antibodies and for studies of the properties of viral proteins.

Authors:  D K Braun; L Pereira; B Norrild; B Roizman
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

9.  Infectivity and glycoprotein processing of herpes simplex virus type 1 grown in a ricin-resistant cell line deficient in N-acetylglucosaminyl transferase I.

Authors:  G Campadelli-Fiume; L Poletti; F Dall'Olio; F Serafini-Cessi
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

10.  Inhibition of glycosylation of bovine herpesvirus 1 glycoproteins by the thymidine analog (E)-5-(2 Bromovinyl)-2'-deoxyuridine.

Authors:  V Misra; R C Nelson; L A Babiuk
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.